Indoco Remedies Ltd

BSE | NSE | CONTACT US

HOME
ABOUT US
BUSINESS
R&D
FACILITIES
- Manufacturing Excellence
- Clinical Research
INVESTORS
MEDIA
CSR
HUMAN RESOURCES
- Life At Indoco
- Careers

Corporate Governance Report
Investors
Home

INVESTORS

Disclosures under Regulation
46 of SEBI Listing Regulations
Contact Details of KMP
Financials

Quarterly Results/Annual
Reports
Subsidiaries Annual Report
Concall Transcripts

Announcements

Intimation to Stock Exchange
MDA
Notice of Meetings
Newspaper Advertisement

Shareholder Information

Investor Relations
ESOP Disclosure
Shareholding Pattern
Unpaid Dividends
Corporate Governance
Details of Equity Shares liable
for transfer to IEPF
Secretarial Compliance Report
Extract of Annual Return
Memorandum and Articles of
Association
Employee Stock Option
Plan 2022

Postal Ballot
Investor Presentation
Investor Grievances
Investor / Analysts Meetings
eVoting / Poll Results
Message From Management
Chairman's Message at AGM
Corporate Policies
Archives

Corporate Governance Report

2024-2025
2023-2024
2022-2023

YEAR 2024-2025

Integrated Corporate Governance Report for the quarter ended March 31, 2025
Integrated Corporate Governance Report for the Quarter ended December 31, 2024
Corporate Governance Report for the Quarter ended December 31, 2024
Corporate Governance Report for the Quarter ended September 30, 2024
Corporate Governance Report for the quarter ended June 30, 2024

YEAR 2023-2024

Corporate Governance Report for the quarter ended March 31, 2024
Corporate Governance Report for the quarter ended December 31, 2023
Corporate Governance Report for the Quarter ended September 30, 2023
Corporate Governance Report for the quarter ended June 30, 2023

YEAR 2022-2023

Corporate Governance Report for the quarter ended March 31, 2023
Corporate Governance Report for the quarter ended December 31, 2022
Corporate Governance Report for the quarter and half-year ended September 30, 2022
Corporate Governance Report for the quarter ended June 30, 2022

© INDOCO REMEDIES LTD. ALL RIGHTS RESERVED

Adverse Event Reporting / Hindi | Privacy Policy | Disclaimer | | |

statistics